Search Results - "Puchinda, D"

Factors affecting chemistry of reduction-mediated 99mTc-labelling of monoclonal antibodies and polyclonal human immunoglobulins by Boonkitticharoen, V, Puchinda, D, Ayudhya, A N, Kraiphibul, P

“…In developing a new method for preparing a radiopharmaceutical for clinical investigation, a thorough understanding of reaction stoichiometry is crucial in…”
Get more information

Reduction-mediated 99mTc-labeling of antitumor monoclonal antibodies: effect of increasing specific activity on antibody binding kinetics by Boonkitticharoen, V, Puchinda, D, Chouplywech, P, Jalayondeja, W

“…Reduction-mediated 99mTc-labeling of antibodies has gained widespread acceptance in preparation of tumor imaging agents. Increased specific activity to enhance…”
Get more information

Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy by Sirisriro, R, Boonkitticharoen, V, Kraiphibul, P, Ratanatharathorn, V, Sumboonnanon, K, Kanjanapitak, A, Kuhapremma, T, Sritara, C, Puchinda, D, Chouplywech, P, Jalayondeja, V, Pekanan, P, Rochanawutanon, M, Intaramarn, C, Ayudhya, A N, Chokesuwathana, P

“…This study shows that a new monoclonal antibody (IOR-CEA1) labeled with technetium-99m has high diagnostic efficacy for colorectal adenocarcinoma. This…”
Get more information